ADAM33: a novel therapeutic target for asthma

Author： Powell Robert M Hamilton Lynnsey M Holgate Stephen T Davies Donna E Holloway John W

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.7, Iss.4, 2003-08, pp. : 485-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adenosine A2B receptors: a novel therapeutic target in asthma?

By Feoktistov I. Biaggioni I. Polosa R. Holgate S.T.

Trends in Pharmacological Sciences, Vol. 19, Iss. 4, 1998-04 ,pp. : 148-153

Elsevier

Access to resources Recommend Favorite

ADAM17 as a Therapeutic Target in Multiple Diseases

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2319-2335

Bentham Science Publishers

Access to resources Recommend Favorite

ADAM10 as a Therapeutic Target for Cancer and Inflammation

Current Pharmaceutical Design, Vol. 15, Iss. 20, 2009-07 ,pp. : 2288-2299

Bentham Science Publishers

Access to resources Recommend Favorite

IL-33: a promising therapeutic target for rheumatoid arthritis?

By Yuan Feng-Lai Li Xia Lu Wei-Guo Li Cheng-Wan Xu Rui-Sheng Dong Jian

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 5, 2011-05 ,pp. : 529-534

Informa Healthcare

Access to resources Recommend Favorite

IL-13: A Promising Therapeutic Target for Bronchial Asthma

Current Medicinal Chemistry, Vol. 13, Iss. 19, 2006-08 ,pp. : 2291-2298

Bentham Science Publishers

Access to resources Recommend Favorite